DexCom
DXCM
DXCM
917 hedge funds and large institutions have $41.8B invested in DexCom in 2022 Q4 according to their latest regulatory filings, with 180 funds opening new positions, 325 increasing their positions, 316 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3% more repeat investments, than reductions
Existing positions increased: 325 | Existing positions reduced: 316
0.92% more ownership
Funds ownership: 94.71% → 95.63% (+0.92%)
1% less call options, than puts
Call options by funds: $636M | Put options by funds: $641M
Holders
917
Holding in Top 10
26
Calls
$636M
Puts
$641M
Top Buyers
| 1 | +$301M | |
| 2 | +$254M | |
| 3 | +$179M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$152M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$123M |
Top Sellers
| 1 | -$805M | |
| 2 | -$534M | |
| 3 | -$133M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$121M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$91.1M |